A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial

Affiliations

• ¹ Divison of Hematology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
• ² Department of Medicine, Division of Hematology Oncology, UCLA School of Medicine, Los Angeles, California, USA.
• ³ Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, UK.
• ⁴ Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.
• ⁵ Department of Clinical and Non-Clinical Research, Pharmacosmos A/S, Holbaek, Denmark.
• ⁶ Department of Renal Medicine, Hull University Teaching Hospitals NHS Trust, Kingston upon Hull, UK.